Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial.

Saved in:
Bibliographic Details
Title: Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial.
Authors: Chong WQ; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Low JL; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Tay JK; Department of Otolaryngology, Head and Neck Surgery, National University Hospital, Singapore; Department of Otolaryngology, Head and Neck Surgery, National University of Singapore, Singapore., Le TBU; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Goh GS; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Sooi K; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Teo HL; Department of Medical Oncology, Tan Tock Seng Hospital, Singapore., Cheo SW; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Wong RT; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Samol J; Department of Medical Oncology, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Singapore; School of Medicine, Johns Hopkins University, Baltimore, MD, USA., Lim MY; Department of Otorhinolaryngology and Head and Neck Surgery, Tan Tock Seng Hospital, Singapore., Li H; Department of Otorhinolaryngology and Head and Neck Surgery, Tan Tock Seng Hospital, Singapore., Shirgaonkar N; Genome Institute of Singapore, Agency of Science, Technology and Research, Singapore., Chia S; Genome Institute of Singapore, Agency of Science, Technology and Research, Singapore., Wang L; Department of Pharmacology, National University of Singapore, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Gopinathan A; Department of Diagnostic Imaging, National University Hospital, Singapore., Eu DK; Department of Otolaryngology, Head and Neck Surgery, National University Hospital, Singapore., Tsang RK; Department of Otolaryngology, Head and Neck Surgery, National University Hospital, Singapore; Department of Otolaryngology, Head and Neck Surgery, National University of Singapore, Singapore., Loh KS; Department of Otolaryngology, Head and Neck Surgery, National University Hospital, Singapore; Department of Otolaryngology, Head and Neck Surgery, National University of Singapore, Singapore., Toh HC; National Cancer Centre, Singapore., Syn N; Department of Pathology, National University of Singapore, Singapore., Kong LR; Department of Pharmacology, National University of Singapore, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Dasgupta R; Genome Institute of Singapore, Agency of Science, Technology and Research, Singapore., Tai BC; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore., Lim YC; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Goh BC; Department of Haematology-Oncology, National University Cancer Institute, Singapore; Department of Pharmacology, National University of Singapore, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore. Electronic address: phcgbc@nus.edu.sg.
Source: The Lancet. Oncology [Lancet Oncol] 2025 Feb; Vol. 26 (2), pp. 175-186. Date of Electronic Publication: 2025 Jan 15.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(24)00677-6